InvestorsHub Logo
Followers 144
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: biowreck post# 46627

Friday, 04/03/2015 8:04:44 AM

Friday, April 03, 2015 8:04:44 AM

Post# of 426489
No, Anchor SPA was written based on the assumption that favorable changes in the lipid profile would translate into a benefit on clinical outcomes.

FDA notified Amarin in October 2013 (rescinded the SPA) that assumption is not enough, "substantial evidence" is necessary to determining the efficacy of V.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News